A comprehensive view of Envision Science. This page highlights a small sample of our full coverage.
For real-time access, please log in to your Health Care Sector Market Intelligence Service.
Quest Diagnostics partners with Envision Sciences to launch a novel prostate cancer biomarker test aimed at improving cancer diagnosis and grading; the test uses Envision's proprietary biomarker and immunohistochemistry technology
Published:
July 13, 2023
by Quest Diagnostics Inc.
|
Ask us about our Health Care Sector market view